Avanir Pharma Revenue, Profits - AVNR Annual Income Statement

Add to My Stocks
$16.96 $0 (0%) AVNR stock closing price Jan 13, 2015 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Avanir Pharma stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for AVNR which shows a YOY revenue growth of 52.63% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Avanir Pharma assets and Avanir Pharma free cash flow, Avanir Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2014 is $-50.43M and the 2014 revenue is $115.02M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep2014201320122011201020092008
Avanir Pharma Revenues or Net Sales
115.02M75.36M41.27M10.49M2.89M4.17M6.95M
Cost Of Goods Sold (COGS)3.52M4.14M2.12M---1.21M
Avanir Pharma Gross Profit
111.5M71.21M39.15M10.04M2.69M4.09M5.74M
Research & Development Expense44M49.5M23.06M15.25M13.32M15.86M14.11M
Selling General & Admin Expense113.84M93.13M74.49M55.42M16.47M10.15M10.59M
Income Before Depreciation Depletion Amortization-46.34M-71.42M-58.4M-60.62M-27.09M-21.92M-18.96M
Depreciation Depletion Amortization-------
Non Operating Income-0.77M-----0.06M3.59M
Interest Expense3.31M4.09M1.38M----
Avanir Pharma Pretax Income
-50.43M-75.47M-59.74M-60.62M-26.69M-21.99M-15.9M
Provision for Income Taxes-------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-50.43M-75.47M-59.74M-60.63M-26.69M-21.99M-15.91M
Extraordinary Items & Discontinued Operations-------1.58M
Avanir Pharma Profit/ Loss (Net Income)
-50.43M-75.47M-59.74M-60.63M-26.69M-21.99M-17.49M
Average Shares used to compute Diluted EPS161.27M142.27M133.36M119.41M89M78.57M58.89M
Average Shares used to compute Basic EPS161.27M142.27M133.36M119.41M89M78.57M58.89M
Income Before Nonrecurring Items-50.44M-75.48M-59.74M-60.63M-26.7M-22M-15.9M
Income from Nonrecurring Items-------
Avanir Pharma Earnings Per Share Basic Net
-0.31-0.53-0.45-0.51-0.30-0.28-0.27
Avanir Pharma Earnings Per Share Diluted Net
-0.31-0.53-0.45-0.51-0.30-0.28-0.27
EPS Diluted Before Nonrecurring Items-0.31-0.53-0.45-0.51-0.30-0.28-0.27
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Avanir Pharma stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $115.02M for this year of 2014. Our Avanir Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. AVNR stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The AVNR financials along with Avanir Pharma historical stock prices provide a lot of details about the firm.